language_icon
EN
HI

Sai Parenteral's Share price

SAIPARENT

482.65

0.90 (0.19%)
NSE
BSE
Last updated on 22 Apr, 2026 | 15:08 IST
Today's High

490.55

Today's Low

457.70

52 Week Low

400.00

52 Week High

526.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sai Parenteral's Chart

Sai Parenteral's Share Key Metrics

Volume
1.48 L
Market Cap
2128.33 CR
LTQ@LTP
9@482.65
ATP
481.78
Var Margin
25 %
Circuit Range
385.4-578.1
Delivery %
64 %
Value
7.15 CR
ASM/GSM
No
Market Lot
1

Summary

Sai Parenteral's share price stands at ₹482.65 at 22 Apr, 2026 | 15:08. The stock Sai Parenteral's intraday movement has stayed between ₹457.70 and ₹490.55, while on a 52-week basis it has fluctuated from ₹400.00 to ₹526.30.
In terms of trading activity, Sai Parenteral's has recorded a volume of 148318 shares. The Sai Parenteral's has a market cap of ₹44179231. The stock’s Average Traded Price (ATP) stands at ₹48178, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9, 48265.
The Sai Parenteral's operates within a circuit range of ₹385.4-578.1 – ₹385.4-578.1, with a Value of ₹7.15 CR. The Delivery Percentage for the day is 64%. Additionally, Sai Parenteral's currently falls under the No framework, and trades with a market lot size of 1.

Sai Parenteral's Fundamentals

View More
P/E Ratio

150.29

P/B Ratio

4.18

Div. Yield

0

Sector P/E

63.84

Sector P/B

3.48

Sec. Div. Yield

0.57

Sai Parenteral's Resistance and Support

Pivot 483.18

Resistance

First Resistance

497.51

Second Resistance

513.28

Third Resistance

527.61

Support

First Support

467.41

Second Support

453.08

Third Support

437.31

Sai Parenteral's Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

51.16%

Mutual Fund

3.81%

Insurance

2.89%

Foreign Institutional Investors

5.73%

Domestic Institutional Investors

6.16%

Retail

30.26%

Others

-0.01%

Total Promoters
MAR '26
51.16%

Sai Parenteral's Corporate Actions

DateAgenda
2026-04-20Others

Sai Parenteral's News

Sai Parenterals Ltd - 544742 - Board Meeting Outcome for Outcome Of Board Meeting

Sai Parenterals board approved an unsecured loan of AUD 1.75 million, equivalent to ₹11.91 crores, to its wholly-owned subsidiary Sai Singapore Pte. Ltd. This financial assistance is for downstream investment in Noumed Pharmaceuticals PTY Limited, Australia.
Apr 20 2026 14:04:00

Sai Parenterals Ltd - 544742 - Board Meeting Intimation for INTIMATION OF BOARD MEETING WHICH IS PROPOSED TO BE HELD ON 20TH OF APRIL 2026

Sai Parenterals' Board of Directors will meet on April 20, 2026. The meeting agenda includes a proposal to invest in or lend to Noumed Pharmaceuticals Pty Limited, an Australian step-down subsidiary.
Apr 14 2026 20:04:00

About Sai Parenteral's

NSE : 761675  
BSE : 544742  
ISIN : INE0H9F01037  

Our Company was originally incorporated as ‘Sai Parenteral’s Private Limited’ a private limited company under the Companies Act 1956 pursuant to a certificate of incorporation dated January 12 2001 issued by the Registrar of Companies Andhra Pradesh at Hyderabad. Thereafter our Company was converted into a public limited company pursuant to resolution of our Board dated December 24 2021 and a special resolution of our Shareholders dated January 05 2022 and consequently the name of our Company was changed to ‘Sai Parenteral’s Limited’ and a fresh certificate of incorporation consequent upon conversion to public limited company dated January 17 2022 was issued to our Company by the RoC.Major Events and Milestones:2001- Company was incorporated as a Private Limited Company under the name of Sai Parenteral’s Private Limited.2016- Change in the ownership of the Company due to acquisition of Equity Shares by our Promoters from the erstwhile promoters of the Company.- Acquired Unit-I and Unit-II.2021- Launch of Prefilled technology equipment in Unit-I.2022- Acquired Unit III and related business from Reichindia Pharma Limited. For details see “Acquisition of Business undertaking of Reichindia Pharma Limited on a slump sale basis” on page 270.- Acquired Unit IV and related business from Medreich Limited. For details see “Acquisition of Business undertaking of Medreich Limited on a slump sale basis” on page 271.2023- Incorporated SP Analytics Private Limited one of our Subsidiary- Our Company achieved a turnover of ? 1000 million2024- Our Company acquired 100 % shareholding of Revat Laboratories Private Limited pursuant to which it became a wholly owned subsidiary of our Company.2025- Incorporated a wholly owned subsidiary Sai Parenterals Pte. Limited in Singapore.- Acquisition of foreign step-down subsidiaries Noumed Pharmaceuticals Pty Limited in Australia and Noumed Pharmaceuticals Limited in New Zealand.

Read More

Sai Parenteral's Management

NamePosition
Anil Kumar KarusalaChairman & Managing Director
Vijitha GorrepatiWhole Time Director
View More

Sai Parenteral's FAQs

The Buying Price of Sai Parenteral's share is 482.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sai Parenteral's stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sai Parenteral's, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sai Parenteral's shares is 150.29. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sai Parenteral's shares is 4.18. Useful to assess the stock's value relative to its book value.

To assess Sai Parenteral's’s valuation compare Sector P/E, P/B which are 63.84 & 3.48 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sai Parenteral's is 2128.33 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sai Parenteral's share price is 526.30 & 400.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sai Parenteral's belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost